PMID- 33629307 OWN - NLM STAT- MEDLINE DCOM- 20210914 LR - 20210914 IS - 2284-0729 (Electronic) IS - 1128-3602 (Linking) VI - 25 IP - 3 DP - 2021 Feb TI - Long non-coding RNA UCA1 mediates proliferation and metastasis of laryngeal squamous cell carcinoma cells via regulating miR-185-5p/HOXA13 axis. PG - 1366-1378 LID - 24845 [pii] LID - 10.26355/eurrev_202102_24845 [doi] AB - OBJECTIVE: LncRNA urothelial cancer associated 1 (UCA1) is involved in the development of laryngeal squamous cell carcinoma (LSCC), however, its specific mechanism is not fully clear. PATIENTS AND METHODS: Quantitative reverse transcription-PCR (RT-qPCR) was conducted to determine the expressions of lncRNA-UCA1, miR-185-5p and homeobox A13 (HOXA13) in LSCC tissues and cell lines. Cell Counting Kit-8 assay, colony formation assay, wound healing assay, Transwell and flow cytometry, DIANA-LncBase V2, as well as Starbase, Targetscan, and Dual-Luciferase reporter gene system were conducted to detect and confirm the crosstalk networks among lncRNA-UCA1, miR-185-5p, and HOXA13. RESULTS: The levels of UCA1 and HOXA13 were significantly higher and the expression of miR-185-5p was reduced in LSCC tissues and cell lines. Moreover, miR-185-5p was predicted as a target gene for lncRNA UCA1, while HOXA13 was the target gene for miR-185-5p. UCA1 siRNA inhibited the proliferation and invasion of LSCC cells, moreover, the proliferation and invasion of LSCC cells were suppressed by miR-185-5p mimics but were enhanced by miR-185-5p inhibitor. UCA1 siRNA and overexpressed HOXA13 reversed the promotive effects of miR-185-5p inhibitor and inhibitory effects of miR-185-5p mimics on cell proliferation and metastasis, respectively. CONCLUSIONS: The current findings reveal the important role of lncRNA UCA1/miR-185-5p/HOXA13 regulatory network in LSCC cells, and potentially provide new insights into the pathogenesis of LSCC. FAU - Sun, Y-D AU - Sun YD AD - Department of Otolaryngology, Hospital of Traditional Chinese Medicine Affiliated to Southwest Medical University, Luzhou, Sichuan Province, China. xingwei_zhouxw@163.com. FAU - Liu, Q AU - Liu Q FAU - Yang, H-X AU - Yang HX FAU - Tian, L AU - Tian L FAU - Wang, J AU - Wang J FAU - Zeng, L AU - Zeng L FAU - Zhou, X-W AU - Zhou XW LA - eng PT - Journal Article PL - Italy TA - Eur Rev Med Pharmacol Sci JT - European review for medical and pharmacological sciences JID - 9717360 RN - 0 (Homeodomain Proteins) RN - 0 (MIRN185 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (RNA, Long Noncoding) RN - 0 (homeobox protein HOXA13) SB - IM MH - Cell Proliferation MH - Head and Neck Neoplasms/*metabolism/pathology MH - Homeodomain Proteins/genetics/*metabolism MH - Humans MH - Laryngeal Neoplasms/*metabolism/pathology MH - MicroRNAs/genetics/*metabolism MH - RNA, Long Noncoding/genetics/*metabolism MH - Squamous Cell Carcinoma of Head and Neck/*metabolism/pathology EDAT- 2021/02/26 06:00 MHDA- 2021/09/15 06:00 CRDT- 2021/02/25 05:50 PHST- 2021/02/25 05:50 [entrez] PHST- 2021/02/26 06:00 [pubmed] PHST- 2021/09/15 06:00 [medline] AID - 24845 [pii] AID - 10.26355/eurrev_202102_24845 [doi] PST - ppublish SO - Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1366-1378. doi: 10.26355/eurrev_202102_24845.